Department of Health
and Human Services (HHS)
and Human Services (HHS)
April 13, 2021
RFA-RM-21-012 - Pilot Projects Investigating Understudied G Protein-Coupled Receptors, Ion Channels, and Protein Kinases (R03 Clinical Trial Not Allowed)
Office of Strategic Coordination (Common Fund)
This Notice clarifies that resubmission applications in response to RFA-RM-21-012, "Pilot Projects Investigating Understudied G Protein-Coupled Receptors, Ion Channels, and Protein Kinases (R03 Clinical Trial Not Allowed)" are due on the same due date as new applications. All applications in response to RFA-RM-21-012 are due on July 15, 2021.
The following section of RFA-RM-21-012 has been modified to reflect this clarification.
Currently Reads:
Part 1. Overview Information
Key Dates
|
Application Due Dates |
Review and Award Cycles |
||||
|
New |
Renewal / Resubmission / Revision (as allowed) |
AIDS |
Scientific Merit Review |
Advisory Council Review |
Earliest Start Date |
|
July 15, 2021 |
Not Applicable |
Not Applicable |
November 2021 |
January 2022 |
April 2022 |
Modified to Read (changes shown in bold italics):
Part 1. Overview Information
Key Dates
|
Application Due Dates |
Review and Award Cycles |
||||
|
New |
Renewal / Resubmission / Revision (as allowed) |
AIDS |
Scientific Merit Review |
Advisory Council Review |
Earliest Start Date |
|
July 15, 2021 |
July 15,2021 |
Not Applicable |
November 2021 |
January 2022 |
April 2022 |
All other aspects of this FOA remain the same.
Karlie Sharma, Ph.D.
National Center for Advancing Translational Sciences (NCATS)
Telephone: 301-451-4965
Email: DruggableGenome@mail.nih.gov